Pharvaris N.V. Insider Trades
NASDAQ: PHVSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 46 · $27.69M
- Shares bought / sold
- 0 / 775.56K
- Net activity
- Net selling $27.7 million
Pharvaris N.V. insider activity
Over the last 12 months, Pharvaris N.V. insiders reported 85 transactions on SEC Form 4: 0 open-market purchases and 46 sales. Insiders bought $0 and sold $27.7 million worth of stock, for net insider selling of $27.7 million. The largest seller was Schikan Johannes Gerardus Christiaan Petrus, with $8.4 million in reported sales.
The most recent filing shows Monges Viviane (Director) reporting a transaction in 11,969 shares at $8.05 on Sep 23, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put PHVS's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
PHVS insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 23, 2026 | Monges VivianeDirector | Sale | 11,969 | $395.52K | Form 4 |
| Sep 23, 2026 | Monges VivianeDirector | Option exercise | 11,969 | $96.35K | Form 4 |
| Sep 22, 2026 | Schikan Johannes Gerardus Christiaan PetrusDirector | Sale | 800 | $28.95K | Form 4 |
| Sep 22, 2026 | Schikan Johannes Gerardus Christiaan PetrusDirector | Option exercise | 800 | $16.00K | Form 4 |
| Sep 22, 2026 | Lu PengPresident | Option exercise | 45,308 | $117.35K | Form 4 |
| Sep 21, 2026 | Nassif David W.CFO / CLO | Gift | 500 | — | Form 4 |
| Sep 21, 2026 | Nassif David W.CFO / CLO | Sale | 6,000 | $218.80K | Form 4 |
| Sep 17, 2026 | Modig BerndtChief Executive Officer | Option exercise | 300,000 | $10.50M | Form 4 |
| Sep 17, 2026 | Lesage AnneChief Early Development | Sale | 20,000 | $765.47K | Form 4 |
| Sep 17, 2026 | Glassman RobertDirector | Sale | 14,493 | $558.81K | Form 4 |
| Sep 17, 2026 | Glassman RobertDirector | Option exercise | 14,493 | $262.90K | Form 4 |
| Sep 17, 2026 | Schikan Johannes Gerardus Christiaan PetrusDirector | Sale | 200,000 | $7.00M | Form 4 |
| Sep 17, 2026 | Bjork ElisabethDirector | Sale | 52,500 | $1.99M | Form 4 |
| Sep 17, 2026 | Bjork ElisabethDirector | Option exercise | 17,500 | $317.45K | Form 4 |
| Sep 17, 2026 | Bjork ElisabethDirector | Option exercise | 35,000 | $503.65K | Form 4 |
| Sep 17, 2026 | Lu PengPresident | Sale | 100,000 | $3.50M | Form 4 |
| Sep 17, 2026 | Lu PengPresident | Option exercise | 100,000 | $259.00K | Form 4 |
| Sep 15, 2026 | Souverijns WimChief Commercial Officer | Sale | 6,090 | $237.45K | Form 4 |
| Sep 15, 2026 | Glassman RobertDirector | Sale | 8,667 | $331.72K | Form 4 |
| Sep 15, 2026 | Glassman RobertDirector | Option exercise | 8,667 | $193.36K | Form 4 |
| Sep 15, 2026 | Abele Stefan AndreasChief Technical Ops Officer | Sale | 1,400 | $54.94K | Form 4 |
| Sep 15, 2026 | Abele Stefan AndreasChief Technical Ops Officer | Sale | 45,000 | $1.72M | Form 4 |
| Sep 15, 2026 | Abele Stefan AndreasChief Technical Ops Officer | Option exercise | 45,000 | $738.00K | Form 4 |
| Sep 14, 2026 | Modig BerndtChief Executive Officer | Sale | 2,291 | $90.28K | Form 4 |
| Sep 14, 2026 | Lu PengPresident | Tax withholding | 117 | $4.45K | Form 4 |
| Sep 14, 2026 | Souverijns WimChief Commercial Officer | Sale | 20,000 | $786.13K | Form 4 |
| Sep 14, 2026 | Souverijns WimChief Commercial Officer | Option exercise | 20,000 | $348.60K | Form 4 |
| Sep 11, 2026 | Lu PengPresident | Tax withholding | 109 | $4.09K | Form 4 |
| Sep 11, 2026 | Lu PengPresident | Sale | 15,000 | $601.95K | Form 4 |
| Sep 11, 2026 | Lu PengPresident | Option exercise | 15,000 | $38.85K | Form 4 |
| Sep 10, 2026 | Lesage AnneChief Early Development | Sale | 30,000 | $1.15M | Form 4 |
| Sep 10, 2026 | Lesage AnneChief Early Development | Option exercise | 30,000 | $241.50K | Form 4 |
| Sep 9, 2026 | Glassman RobertDirector | Sale | 8,000 | $300.40K | Form 4 |
| Sep 9, 2026 | Glassman RobertDirector | Option exercise | 8,000 | $160.00K | Form 4 |
| Sep 8, 2026 | Lu PengPresident | Sale | 15,000 | $610.13K | Form 4 |
| Sep 8, 2026 | Lu PengPresident | Option exercise | 15,000 | $38.85K | Form 4 |
| Aug 14, 2026 | Modig BerndtChief Executive Officer | Sale | 2,292 | $79.69K | Form 4 |
| Aug 12, 2026 | Lu PengPresident | Tax withholding | 117 | $4.03K | Form 4 |
| Aug 11, 2026 | Lu PengPresident | Tax withholding | 109 | $3.80K | Form 4 |
| Jul 13, 2026 | Modig BerndtChief Executive Officer | Sale | 2,292 | $80.15K | Form 4 |
| Jul 12, 2026 | Lu PengChief Medical Officer | Tax withholding | 117 | $4.10K | Form 4 |
| Jul 11, 2026 | Lu PengChief Medical Officer | Tax withholding | 109 | $3.82K | Form 4 |
| Jun 30, 2026 | Lesage AnneChief Early Development | Sale | 30,703 | $1.09M | Form 4 |
| Jun 30, 2026 | Lesage AnneChief Early Development | Sale | 27,872 | $988.89K | Form 4 |
| Jun 30, 2026 | Lesage AnneChief Early Development | Option exercise | 24,900 | $200.44K | Form 4 |
| Jun 30, 2026 | Lesage AnneChief Early Development | Option exercise | 2,972 | $7.70K | Form 4 |
| Jun 30, 2026 | Schikan Johannes Gerardus Christiaan PetrusDirector | Sale | 30,712 | $1.09M | Form 4 |
| Jun 29, 2026 | Schikan Johannes Gerardus Christiaan PetrusDirector | Sale | 2,400 | $84.25K | Form 4 |
| Jun 29, 2026 | Lesage AnneChief Early Development | Sale | 6,997 | $245.23K | Form 4 |
| Jun 29, 2026 | Lesage AnneChief Early Development | Sale | 8,300 | $290.91K | Form 4 |
| Jun 29, 2026 | Lesage AnneChief Early Development | Sale | 2,300 | $80.79K | Form 4 |
| Jun 29, 2026 | Lesage AnneChief Early Development | Option exercise | 4,200 | $33.81K | Form 4 |
| Jun 29, 2026 | Lesage AnneChief Early Development | Option exercise | 4,100 | $10.62K | Form 4 |
| Jun 29, 2026 | Lesage AnneChief Early Development | Option exercise | 900 | $7.25K | Form 4 |
| Jun 29, 2026 | Lesage AnneChief Early Development | Option exercise | 1,400 | $3.63K | Form 4 |
| Jun 29, 2026 | Schikan Johannes Gerardus Christiaan PetrusDirector | Sale | 6,888 | $241.45K | Form 4 |
| Jun 26, 2026 | Lu PengChief Medical Officer | Sale | 14,700 | $499.85K | Form 4 |
| Jun 26, 2026 | Lu PengChief Medical Officer | Option exercise | 14,700 | $38.07K | Form 4 |
| Jun 25, 2026 | Lu PengChief Medical Officer | Sale | 3,400 | $119.31K | Form 4 |
| Jun 25, 2026 | Lu PengChief Medical Officer | Sale | 11,600 | $399.67K | Form 4 |
| Jun 25, 2026 | Lu PengChief Medical Officer | Option exercise | 15,000 | $38.85K | Form 4 |
| Jun 25, 2026 | Lesage AnneChief Early Development | Sale | 2,300 | $80.79K | Form 4 |
| Jun 25, 2026 | Lesage AnneChief Early Development | Sale | 2,300 | $80.77K | Form 4 |
| Jun 25, 2026 | Lesage AnneChief Early Development | Option exercise | 900 | $7.25K | Form 4 |
| Jun 25, 2026 | Lesage AnneChief Early Development | Option exercise | 1,400 | $3.63K | Form 4 |
| Jun 18, 2026 | Lu PengChief Medical Officer | Sale | 300 | $10.20K | Form 4 |
| Jun 18, 2026 | Lu PengChief Medical Officer | Option exercise | 300 | $777 | Form 4 |
| Jun 15, 2026 | Modig BerndtChief Executive Officer | Sale | 100 | $3.15K | Form 4 |
| Jun 15, 2026 | Modig BerndtChief Executive Officer | Sale | 2,191 | $68.03K | Form 4 |
| Jun 12, 2026 | Lu PengChief Medical Officer | Tax withholding | 117 | $3.77K | Form 4 |
| Jun 11, 2026 | Lu PengChief Medical Officer | Tax withholding | 109 | $3.43K | Form 4 |
| Jun 4, 2026 | Nijdam AnnaPrincipal Accounting Officer | Sale | 2,670 | $82.43K | Form 4 |
| May 22, 2026 | Nijdam AnnaPrincipal Accounting Officer | Sale | 5,501 | $169.08K | Form 4 |
| May 22, 2026 | Nijdam AnnaPrincipal Accounting Officer | Option exercise | 5,501 | $110.02K | Form 4 |
| May 21, 2026 | Nijdam AnnaPrincipal Accounting Officer | Sale | 1,829 | $55.97K | Form 4 |
| May 21, 2026 | Nijdam AnnaPrincipal Accounting Officer | Option exercise | 1,829 | $36.58K | Form 4 |
| May 21, 2026 | Nassif David W.CFO / CLO | Sale | 10,000 | $303.08K | Form 4 |
| May 21, 2026 | Monges VivianeDirector | Sale | 9,667 | $292.85K | Form 4 |
| May 20, 2026 | Bjork ElisabethDirector | Sale | 10,000 | $293.17K | Form 4 |
| May 20, 2026 | Bjork ElisabethDirector | Option exercise | 10,000 | $80.50K | Form 4 |
| May 18, 2026 | Modig BerndtChief Executive Officer | Sale | 2,292 | $66.98K | Form 4 |
| May 15, 2026 | Glassman RobertDirector | Sale | 4,667 | $139.15K | Form 4 |
| May 15, 2026 | Glassman RobertDirector | Sale | 5,333 | $159.09K | Form 4 |
| May 15, 2026 | Glassman RobertDirector | Option exercise | 5,333 | $118.98K | Form 4 |
| May 15, 2026 | Abele Stefan AndreasChief Technical Ops Officer | Sale | 8,748 | $260.86K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4